Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.76 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.76 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.76 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | DGKA | P23743 | 1/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | SELP | P16109 | 1/20 | 0.56 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25616141 | 0.96 | PRKCA (0.71) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21477699 | 0.92 | ALDH1A1 (0.79) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21641598 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21443903 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2178688 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL23225841 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21439775 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL25386238 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL25386239 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL21641597 | 0.90 | PRKCA (0.86) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118265522-A | Lipid-based RNA formulations suitable for treatment | 生物技术欧洲股份公司 | 2024-06-28 | — | — | CN | claimed |
| WO-2025092744-A1 | AMINOCHOLESTEROL DERIVATIVE, NANOPARTICLES CONTAINING AMINOCHOLESTEROL DERIVATIVE AND USE THEREOF | 北京先声祥瑞生物制品股份有限公司 | 2025-05-08 | — | — | WO | disclosed |
| WO-2025077899-A1 | LYOPHILIZED PREPARATION OF NUCLEIC ACID DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 北京先声祥瑞生物制品股份有限公司 | 2025-04-17 | — | — | WO | disclosed |
| WO-2013032643-A2 | LIPIDS CAPABLE OF CONFORMATIONAL CHANGE AND THEIR USE IN FORMULATIONS TO DELIVER THERAPEUTIC AGENTS TO CELLS | DICERNA PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | WO | disclosed |